Clinical Trial Update: Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring decitabine for myelodysplastic syndrome after azacitidine failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Dacogen (decitabine)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: King's College London | Conditions: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 2 | Status: UNKNOWN